AstraZeneca, Oxford discrepancy ‘worrying’ – Hepburn Advocate

AstraZeneca and Oxford University have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine, a rare instance of public dissension between major institutions collaborating on a pivotal project.
The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose.
This diverged from the original plan of two full doses, given…

Click here to view the original article.